Cargando…
PD-1/PD-L1 pathway blockade works as an effective and practical therapy for cancer immunotherapy
Cancer immunotherapy has greatly advanced in recent years, and PD-1/PD-L1 blocking therapy has become a major pillar of immunotherapy. Successful clinical trials of PD-1/PD-L1 blocking therapies in cancer treatments have benefited many patients, which promoted the Food and Drug Administration (FDA)...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Chinese Anti-Cancer Association
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994550/ https://www.ncbi.nlm.nih.gov/pubmed/29951336 http://dx.doi.org/10.20892/j.issn.2095-3941.2017.0086 |